Related Experiment Videos
[Pilomatrix carcinoma: histologic and immunohistochemical features. Two studies]
Thomas Petit1, Maggy Grossin, Eve Lefort
1Service d'Anatomie Pathologique, Hôpital Bichat-Claude Bernard, Paris. tom.petit@online.fr
Annales De Pathologie
|May 14, 2003
Summary
Malignant pilomatricoma, a rare hair follicle tumor, is challenging to diagnose due to similarities with benign forms. Wide surgical resection is crucial for treatment, significantly reducing recurrence risk.
Area of Science:
- Dermatology
- Oncology
- Pathology
Background:
- Malignant pilomatricoma is a rare, aggressive hair follicle tumor first described in 1980.
- Histological diagnosis is difficult due to shared features with benign pilomatricoma.
Observation:
- This deep dermal-hypodermal tumor lacks epidermal connection, featuring basaloid cells, necrosis, and ghost cells.
- Immunohistochemistry offers limited diagnostic value; diagnosis relies on morphological assessment.
- Key diagnostic criteria include infiltration, necrosis, mitotic figures, and vascular/neural invasion.
Findings:
- Surgical wide resection is the primary treatment, reducing local recurrence by 50%.
- Malignant pilomatricoma has a high propensity for metastasis to bone, lungs, and lymph nodes.
- Distinguishing de novo origin from malignant transformation of benign pilomatricoma remains unclear.
Implications:
- Accurate histological evaluation is critical for appropriate management of malignant pilomatricoma.
- Understanding metastatic potential guides patient monitoring and treatment strategies.
- Further research is needed to clarify the pathogenesis and specific diagnostic markers.